Medpace Q3 EPS, Revenue Increase; Adjusts 2024 Outlook; Shares Fall After Hours

MT Newswires Live

Oct 22, 2024

Medpace (MEDP) reported Q3 earnings Monday of $3.01 per diluted share, up from $2.22 a year earlier.

Analysts polled by Capital IQ expected $2.78.

Revenue for the quarter ended Sept. 30 was $533.3 million, up from $492.5 million a year earlier.

Analysts surveyed by Capital IQ expected $541 million.

The company now expects 2024 revenue between $2.09 billion and $2.13 billion from previous guidance between $2.125 billion and $2.175 billion.

Analysts polled by Capital IQ expect $2.14 billion.

The company now expects diluted EPS between $11.71 and $12.09 from previous guidance between $11.24 and $11.93.

Analysts surveyed by Capital IQ expect $11.56.

The company's shares were falling past 10% in recent after-hours activity.

Price: 312.96, Change: -39.96, Percent Change: -11.32

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2477950811"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2477950811\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2477950811?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-22 04:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2477950811","market":"nz","top_or_hot":-1,"title":"Medpace Q3 EPS, Revenue Increase; Adjusts 2024 Outlook; Shares Fall After Hours","media":"MT Newswires Live","content":"<html><body><p> Medpace (MEDP) reported Q3 earnings Monday of $3.01 per diluted share, up from $2.22 a year earlier.</p><p>Analysts polled by Capital IQ expected $2.78.</p><p>Revenue for the quarter ended Sept. 30 was $533.3 million, up from $492.5 million a year earlier.</p><p>Analysts surveyed by Capital IQ expected $541 million.</p><p>The company now expects 2024 revenue between $2.09 billion and $2.13 billion from previous guidance between $2.125 billion and $2.175 billion.</p><p>Analysts polled by Capital IQ expect $2.14 billion.</p><p>The company now expects diluted EPS between $11.71 and $12.09 from previous guidance between $11.24 and $11.93.</p><p>Analysts surveyed by Capital IQ expect $11.56.</p><p>The company's shares were falling past 10% in recent after-hours activity.</p><p>Price: 312.96, Change: -39.96, Percent Change: -11.32</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Medpace Q3 EPS, Revenue Increase; Adjusts 2024 Outlook; Shares Fall After Hours</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMedpace Q3 EPS, Revenue Increase; Adjusts 2024 Outlook; Shares Fall After Hours\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-10-22 04:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Medpace (MEDP) reported Q3 earnings Monday of $3.01 per diluted share, up from $2.22 a year earlier.</p><p>Analysts polled by Capital IQ expected $2.78.</p><p>Revenue for the quarter ended Sept. 30 was $533.3 million, up from $492.5 million a year earlier.</p><p>Analysts surveyed by Capital IQ expected $541 million.</p><p>The company now expects 2024 revenue between $2.09 billion and $2.13 billion from previous guidance between $2.125 billion and $2.175 billion.</p><p>Analysts polled by Capital IQ expect $2.14 billion.</p><p>The company now expects diluted EPS between $11.71 and $12.09 from previous guidance between $11.24 and $11.93.</p><p>Analysts surveyed by Capital IQ expect $11.56.</p><p>The company's shares were falling past 10% in recent after-hours activity.</p><p>Price: 312.96, Change: -39.96, Percent Change: -11.32</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MEDP","symbol_name":"Medpace Holdings Inc.","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2477950811","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2477950811","pubTimestamp":1729543767,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Medpace  reported Q3 earnings Monday of $3.01 per diluted share, up from $2.22 a year earlier.Analysts polled by Capital IQ expected $2.78.Revenue for the quarter ended Sept. 30 was $533.3 million, up from $492.5 million a year earlier.Analysts surveyed by Capital IQ expected $541 million.The company now expects 2024 revenue between $2.09 billion and $2.13 billion from previous guidance between $2.125 billion and $2.175 billion.Analysts polled by Capital IQ expect $2.14 billion.The company now expects diluted EPS between $11.71 and $12.09 from previous guidance between $11.24 and $11.93.Analysts surveyed by Capital IQ expect $11.56.The company's shares were falling past 10% in recent after-hours activity.Price: 312.96, Change: -39.96, Percent Change: -11.32","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"MEDP":"Medpace Holdings Inc."},"translate_title":"Medpace第三季度每股收益、收入增长；调整2024年展望；盘后股价下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MEDP":1},"content_text":"Medpace (MEDP) reported Q3 earnings Monday of $3.01 per diluted share, up from $2.22 a year earlier.Analysts polled by Capital IQ expected $2.78.Revenue for the quarter ended Sept. 30 was $533.3 million, up from $492.5 million a year earlier.Analysts surveyed by Capital IQ expected $541 million.The company now expects 2024 revenue between $2.09 billion and $2.13 billion from previous guidance between $2.125 billion and $2.175 billion.Analysts polled by Capital IQ expect $2.14 billion.The company now expects diluted EPS between $11.71 and $12.09 from previous guidance between $11.24 and $11.93.Analysts surveyed by Capital IQ expect $11.56.The company's shares were falling past 10% in recent after-hours activity.Price: 312.96, Change: -39.96, Percent Change: -11.32","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}